Bionic Vision has announced plans to move forward with development and commercialization of an implant which would enable partial treatment of retinitis pigmentosa, a genetic disease which breaks down rods overtime. The device will be comprised of an implant behind the retina to stimulate existing cells and an external camera and visual processing unit which transmits images to the implant. The “bionic eye” device is scheduled to begin clinical trials in Australia within the next few months. Read the full article here.
